Erasca (ERAS) is down -46.0%, or -$8.81 to $10.34.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERAS:
- Unusually active option classes on open April 28th
- Erasca falls after disclosing patient died after withdrawing from trial
- Erasca price target raised to $9 from $2 at BofA
- Analyst Maintains Buy on ERAS-0015’s Promising Early Data, Keeps Price Target Unchanged at $20
- Closing Bell Movers: Sanmina jumps over 10% on earnings beat